Advanced Cardiac Therapeutics, Inc.

Description

• Advanced Cardiac Therapeutics, Inc. (ACT), is a medical device company that is developing a novel, temperature-sensing, irrigated, radiofrequency (RF) ablation system for treatment of cardiac arrhythmias. Advanced Cardiac Therapeutics (ACT) was founded with the vision to advance the field of lesion assessment in cardiac catheter ablation in order to improve safety and clinical outcomes for patients. An estimated 12.5 million people globally suffer from symptomatic atrial fibrillation (AF), which significantly increases the risk of stroke and other co-morbidities. Nonetheless, the majority of AF patients remain untreated, with only 300,000 patients undergoing catheter or surgical ablation each year, in large part due to suboptimal outcomes provided by current ablation technologies. ACT's TempaSure technology features patented and clinically validated microwave radiometry technology that can monitor in real-time tissue contact and volumetric temperature in the heart so that physicians can more precisely control and predict lesion formation. This technology holds the promise of providing electrophysiologists with a tool that directly address the main challenge of RF ablation: reliable and accurate knowledge to maximize safe and effective lesion creation.
• 

  Headquarters:2880 Lakeside Drive , Santa Clara, California, United States

  More
• 

  Phone Number:

• 

  Website: https://www.actmed.net

• 

  Employees:8

• 

  Revenue:$1 - 10M

• 

  Legal Name:Advanced Cardiac Therapeutics, Inc.

• Advanced Cardiac Therapeutics, Inc.'s Social Media

  
• Is this data correct?

• |  NAICS Code: 332994  |

  Show More